Valaris Limited
Valaris Limited (VAL) Financial Performance & Income Statement Overview
Explore the financials of Valaris Limited (VAL), including yearly and quarterly data on income, cash flow, and balance sheets.
Valaris Limited (VAL) Income Statement & Financial Overview
Analyze Valaris Limited’s VAL earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $620.70M | $584.40M | $643.10M | $610.10M |
| Cost of Revenue | $448.10M | $449.20M | $493.80M | $468.40M |
| Gross Profit | $172.60M | $135.20M | $149.30M | $141.70M |
| Gross Profit Ratio | $0.28 | $0.23 | $0.23 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $24.40M | $26.70M | $30.60M | $31.80M |
| Operating Expenses | $29.60M | $26.70M | $30.60M | $32.50M |
| Total Costs & Expenses | $477.70M | $465.20M | $524.40M | $500.90M |
| Interest Income | $14.40M | $16.60M | $17.50M | $31.00M |
| Interest Expense | $24.30M | $22.10M | $22.40M | $22.60M |
| Depreciation & Amortization | $33.10M | $33.90M | $31.70M | $29.70M |
| EBITDA | $143.00M | $179.80M | $141.30M | $173.10M |
| EBITDA Ratio | $0.23 | $0.31 | $0.22 | $0.28 |
| Operating Income | $143.00M | $119.20M | $94.90M | $109.20M |
| Operating Income Ratio | $0.23 | $0.20 | $0.15 | $0.18 |
| Other Income/Expenses (Net) | $11.30M | $4.60M | -$7.70M | $11.60M |
| Income Before Tax | $154.30M | $123.80M | $87.20M | $120.80M |
| Income Before Tax Ratio | $0.25 | $0.21 | $0.14 | $0.20 |
| Income Tax Expense | $193.50M | -$6.80M | $24.30M | -$30.00M |
| Net Income | -$37.90M | $133.70M | $64.60M | $149.60M |
| Net Income Ratio | -$0.06 | $0.23 | $0.10 | $0.25 |
| EPS | -$0.53 | $1.88 | $0.89 | $2.07 |
| Diluted EPS | -$0.53 | $1.88 | $0.88 | $2.03 |
| Weighted Avg Shares Outstanding | $71.00M | $72.10M | $72.40M | $72.40M |
| Weighted Avg Shares Outstanding (Diluted) | $71.00M | $72.90M | $73.20M | $73.70M |
The company's financials show resilient growth, with revenue advancing from $610.10M in Q2 2024 to $620.70M in Q1 2025. Gross profit remained healthy with margins at 28% in Q1 2025 compared to 23% in Q2 2024. Operating income hit $143.00M last quarter, sustaining a consistent 23% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $143.00M. Net income dropped to -$37.90M, while earnings per share reached -$0.53. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan